ArticleInflammopharmacology2021
Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.
Simone A Osborne et al.PubMed ↗Publisher ↗
No numbers read from the abstract.